|Articles|October 1, 2011
- BioPharm International-10-01-2011
- Volume 24
- Issue 10
BioPharm International, October 2011 Issue (PDF)
Examining the Outsourcing Relationship
Advertisement
Articles in this issue
over 14 years ago
Education and Training in Biopharmaceutical Developmentover 14 years ago
Trends in Biologics Outsourcingover 14 years ago
Survey Examines Trends in the Outsourcing Relationshipover 14 years ago
Contract Services Spending: Who's Spending What, and Where?over 14 years ago
Global Health Challenges Spur Vaccine Developmentover 14 years ago
Preparing for the Last Warover 14 years ago
Perspectives in MicroRNA Therapeuticsover 14 years ago
How to Choose the Right CMONewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
WHO Finalizes United States’ Withdrawal from Organization: Report
3
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
4
Bio/pharma Manufacturing Professionals Are Staying Put Despite Growing Uncertainty
5
